Medtronic plc
MDTNYSEHealthcare● Active
$80.28
$-1.39(-1.70%)
Market Cap$103.1B
P/E Ratio—
52W High$106.33
52W Low$73.31
Medtronic plc (MDT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MDT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Jun 3, 2026EPS Actual
$1.55
Est. $1.54 · +0.7%
Revenue
$9.81B
Est. $9.62B · +1.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Jun 3, 2026
After Market Close
▲ Beat Revenue🔥 11-Quarter EPS Beat Streak
MDT reports quarterly as a NYSE-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 18, 2026 | $1.39 | — | — | — | $9.56B | — |
| — Q2 FY2026 | Jun 3, 2026 | $1.54 | $1.55 | +0.7% | $9.81B | $9.62B | +1.9% |
| ▲ Q1 FY2026 | Feb 17, 2026 | $1.34 | $1.36 | +1.5% | $9.02B | $8.91B | +1.2% |
| ▲ Q4 FY2025 | Nov 18, 2025 | $1.31 | $1.36 | +3.8% | $8.96B | $8.87B | +1.1% |
| ▲ Q3 FY2025 | Aug 19, 2025 | $1.23 | $1.26 | +2.4% | $8.58B | $8.38B | +2.4% |
| ▲ Q2 FY2025 | May 21, 2025 | $1.58 | $1.62 | +2.5% | $8.93B | $8.82B | +1.2% |
| ▲ Q1 FY2025 | Feb 18, 2025 | $1.36 | $1.39 | +2.2% | $8.29B | $8.33B | -0.4% |
| — Q4 FY2024 | Nov 19, 2024 | $1.25 | $1.26 | +0.8% | $8.40B | $8.27B | +1.6% |
Q3 FY2026
Aug 18, 2026
EPS Actual
—
EPS Est.
$1.39
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 3, 2026
EPS Actual
$1.55
EPS Est.
$1.54
EPS Surpr.
+0.7%
Revenue
$9.81B
Q1 FY2026
Feb 17, 2026Beat
EPS Actual
$1.36
EPS Est.
$1.34
EPS Surpr.
+1.5%
Revenue
$9.02B
Q4 FY2025
Nov 18, 2025Beat
EPS Actual
$1.36
EPS Est.
$1.31
EPS Surpr.
+3.8%
Revenue
$8.96B
Q3 FY2025
Aug 19, 2025Beat
EPS Actual
$1.26
EPS Est.
$1.23
EPS Surpr.
+2.4%
Revenue
$8.58B
Q2 FY2025
May 21, 2025Beat
EPS Actual
$1.62
EPS Est.
$1.58
EPS Surpr.
+2.5%
Revenue
$8.93B
Q1 FY2025
Feb 18, 2025Beat
EPS Actual
$1.39
EPS Est.
$1.36
EPS Surpr.
+2.2%
Revenue
$8.29B
Q4 FY2024
Nov 19, 2024
EPS Actual
$1.26
EPS Est.
$1.25
EPS Surpr.
+0.8%
Revenue
$8.40B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $1.82 | $1.88 | $1.91 | 7 |
| Q1 FY2028 | $1.52 | $1.57 | $1.59 | 7 |
| Q4 FY2027 | $1.46 | $1.51 | $1.53 | 8 |
| Q3 FY2027 | $1.40 | $1.44 | $1.46 | 8 |
| Q2 FY2027 | $1.72 | $1.78 | $1.80 | 8 |
| Q1 FY2027 | $1.39 | $1.44 | $1.46 | 8 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $10.5B | $10.8B | $10.9B | 6 |
| Q1 FY2028 | $9.8B | $10.1B | $10.1B | 6 |
| Q4 FY2027 | $9.7B | $10.0B | $10.1B | 9 |
| Q3 FY2027 | $9.4B | $9.7B | $9.8B | 9 |
| Q2 FY2027 | $10.0B | $10.3B | $10.4B | 9 |
| Q1 FY2027 | $9.3B | $9.6B | $9.7B | 9 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Jun 3, 2026 | +0.7% | $73.75 | $77.95 | +5.69% |
| ▲ Q1 FY2026 | Feb 17, 2026 | +1.5% | $99.49 | $96.41 | -3.10% |
| ▲ Q4 FY2025 | Nov 18, 2025 | +3.8% | $96.28 | $100.80 | +4.69% |
| ▲ Q3 FY2025 | Aug 19, 2025 | +2.4% | $92.81 | $89.90 | -3.14% |
| ▲ Q2 FY2025 | May 21, 2025 | +2.5% | $86.37 | $84.41 | -2.27% |
| ▲ Q1 FY2025 | Feb 18, 2025 | +2.2% | $92.81 | $86.07 | -7.26% |
| ▲ Q4 FY2024 | Nov 19, 2024 | +0.8% | $87.59 | $85.00 | -2.96% |
| ▲ Q3 FY2024 | Aug 20, 2024 | +2.5% | $84.82 | $85.38 | +0.66% |
Q2 FY2026+5.69%
Report Date
Jun 3, 2026
EPS Beat/Miss
+0.7%
Price Before
$73.75
Price After
$77.95
Q1 FY2026-3.10%
Report Date
Feb 17, 2026
EPS Beat/Miss
+1.5%
Price Before
$99.49
Price After
$96.41
Q4 FY2025+4.69%
Report Date
Nov 18, 2025
EPS Beat/Miss
+3.8%
Price Before
$96.28
Price After
$100.80
Q3 FY2025-3.14%
Report Date
Aug 19, 2025
EPS Beat/Miss
+2.4%
Price Before
$92.81
Price After
$89.90
Q2 FY2025-2.27%
Report Date
May 21, 2025
EPS Beat/Miss
+2.5%
Price Before
$86.37
Price After
$84.41
Q1 FY2025-7.26%
Report Date
Feb 18, 2025
EPS Beat/Miss
+2.2%
Price Before
$92.81
Price After
$86.07
Q4 FY2024-2.96%
Report Date
Nov 19, 2024
EPS Beat/Miss
+0.8%
Price Before
$87.59
Price After
$85.00
Q3 FY2024+0.66%
Report Date
Aug 20, 2024
EPS Beat/Miss
+2.5%
Price Before
$84.82
Price After
$85.38
Avg Beat Reaction-0.96%
Beat Rate8 / 8 quarters
Largest Move-7.26% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MDT ends December
Medtronic plc (MDT) most recently reported earnings on June 3, 2026 for Q2 FY2026, posting EPS of $1.55 (in line with the analyst consensus of $1.54). MDT has beaten EPS estimates for 11 consecutive quarters. The next MDT earnings date is expected around September 1, 2026.
Each quarter, investors track MDT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MDT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MDT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MDT earnings · 4 questionsMedtronic plc's next earnings report is expected around September 1, 2026. MDT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MDT historically reports after market close (AMC).
MDT earnings datewhen is MDT earningsMDT next earnings datewhen does MDT report earningsMDT earnings calendar
▸ Source: FMP · Medtronic plc SEC filings · US GAAP · Medtronic plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026